News | November 19, 2025
Sudeep Pharma eyes Rs. 895 crore fundraising from debut on bourses
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Conjugated Estrogens Tablets are indicated for moderate to severe menopausal symptoms, including hot flashes, and for the prevention of postmenopausal osteoporosis in women at significant risk
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
Subscribe To Our Newsletter & Stay Updated
